Business

First Day of Dealings

First Day of Dealings.

articleAvacta Group PlcAugust 8, 20065/company/avacta-group-plc/news/first-day-of-dealings-98
First Day of Dealings

About this update from Avacta Group Plc

[{"type":"text","content":"\n \n Avacta Group plc (formerly Readybuy plc) \n\n First Day of Dealings on AIM \n\nAvacta Group plc (\"the Company\") announces the re-admission of its existing\nordinary shares; the admission of 45,000,000 Placing Shares and the admission\nof 475,530,102 new Ordinary Shares issued pursuant to the Acquisition Agreement\nto trading on AIM today.\n\nA total of 644,857,446 Ordinary Shares were admitted to trading, giving a\nmarket capitalisation for the Company, at the placing price of 2.25p per share,\nof £14.5m.\n\nAt the Extraordinary General Meeting of the Company held on Monday 7 August,\nDaron Lee resigned as a director of the Company; Professor Alastair Smith was\nappointed Chief Executive and Dr. Gwyn Humphreys, Dr. Simon Webster, Dr. Kurt\nBaldwin, Tim Sykes, Professor Tony Robards OBE and Alan Aubrey were appointed\ndirectors of the Company.\n\nProfessor Alastair Smith, Chief Executive, Avacta Group plc, commented:\n\n\"I am delighted that this transaction, leading to our listing on AIM, is on\nschedule and the funds raised will enable us to focus on the development of our\nfirst products. Our relocation to the York Biocentre has been completed\nsuccessfully with a seamless transition of our laboratories and staff.\n\n\"Our focus is on delivering multiple revenue streams for shareholders through a\nrange of products and services designed to identify and rapidly analyse\nsubstances at the molecular level. Such technology will initially be exploited\nthrough applications within the defence, homeland security and\nbiopharmaceutical markets where the need exists for timely analysis of\nchemicals, viruses, bacteria and proteins such as toxins and antibodies.\n\n\"We look forward to an exciting year of progress and anticipate regular\nnewsflow concerning product development and planned collaborative agreements\"\n\n 8th August 2006\n\nEnquiries:\n\nAvacta Group plc Tel: 0870 835 4367 \n \nAlastair Smith, Chief Executive \n \nWH Ireland Limited Tel: 0161 832 2174 \n \nDavid Youngman, Director, Corporate Finance \n \nNexus Financial Ltd Tel: 020 7451 7050 \n \nNicholas Nelson, Director [email protected] \n\nIn accordance with Schedule Two(g) of the AIM Rules, the Company is pleased to\nprovide the information below:-\n\nDirector Age Current directorships Previous directorships \n (last five years) \n \nProfessor...

More updates from Avacta Group Plc